JENNISON ASSOCIATES LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
JENNISON ASSOCIATES LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6,669,386
+77.0%
1,392,356
+109.5%
0.01%
+66.7%
Q1 2023$3,769,042
+0.7%
664,734
-0.6%
0.00%
-25.0%
Q4 2022$3,743,270
+142.6%
668,441
+218.0%
0.00%
+100.0%
Q1 2018$1,543,000
-33.1%
210,198
-7.6%
0.00%0.0%
Q4 2017$2,308,000
-88.2%
227,586
-66.1%
0.00%
-90.5%
Q2 2016$19,482,000
+82.8%
670,639
+67.1%
0.02%
+90.9%
Q1 2016$10,657,000
-23.9%
401,257
+0.6%
0.01%
-21.4%
Q4 2015$13,999,000
+20.6%
398,959
+1.9%
0.01%
+16.7%
Q3 2015$11,610,000
-28.3%
391,700
+0.4%
0.01%
-20.0%
Q2 2015$16,185,000390,0000.02%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 12,682,876$125,560,00040.85%
ARK Investment Management 492,064$4,871,0001.77%
Artal Group S.A. 700,000$6,930,0000.15%
Portolan Capital Management 111,054$1,099,0000.15%
Rock Springs Capital Management LP 220,000$2,178,0000.15%
CQS Cayman LP 162,000$1,604,0000.13%
Opus Point Partners Management, LLC 14,000$139,0000.11%
HAMILTON LANE ADVISORS LLC 14,883$147,0000.10%
Geduld E E 15,000$149,0000.08%
Virtus ETF Advisers LLC 28,148$279,0000.08%
View complete list of SERES THERAPEUTICS INC shareholders